Dr Sunil Badve

O'Shea S; Badve SV; Johnson DW, 2014, 'Erythropoiesis stimulating agent resistance', in Advances in Drug Resistance Research, pp. 120 - 135

Badve SV; Hawley CM; Johnson DW, 2013, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Bose B; Badve SV; Johnson DW, 2013, 'Peritoneal transport status: A risk factor for peritoneal dialysis', in Peritoneal Dialysis: Types, Procedures and Risks Factors, pp. 69 - 94

Zirapury T; van Eps C; Hawley CM; Badve SV; Johnson DW, 2013, 'An overview of erythropoietin therapy', in Erythropoietin: Human Production, Potential Uses and Adverse Effects, pp. 31 - 53

Badve SV; Hawley CM; Johnson DW, 2012, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Badve SV; Beller E; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2010, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', in Badve SV (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd006861.pub2

Chung EYM; Badve SV; Heerspink HJL; Wong MG, 2023, 'Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?', Nephrology, vol. 28, pp. 97 - 108, http://dx.doi.org/10.1111/nep.14130

Bose B; Badve SV; Johnson DW; Hawley C; Jha V; Reidlinger D; Peh CA, 2022, 'Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region', Nephrology, vol. 27, pp. 35 - 43, http://dx.doi.org/10.1111/nep.13953

Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC, 2022, 'Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis', Journal of Nephrology, vol. 35, pp. 1159 - 1170, http://dx.doi.org/10.1007/s40620-022-01268-2

Davies SJ; Zhao J; McCullough KP; Kim Y-L; Wang AY-M; Badve S; Mehrotra R; Kanjanabuch T; Kawanishi H; Robinson BM; Pisoni R; Perl J, 2022, 'International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival', KIDNEY360, vol. 3, pp. 872 - 882, http://dx.doi.org/10.34067/KID.0006922021

Ethier I; Boudville N; McDonald S; Brown F; Kerr PG; Walker R; Holt SG; Badve SV; Cho Y; Hawley C; Robison L; Reidlinger D; Milanzi E; Bieber B; McCullough K; Johnson DW, 2022, 'Representativeness of the PDOPPS cohort compared to the Australian PD population', Peritoneal Dialysis International, vol. 42, pp. 403 - 414, http://dx.doi.org/10.1177/08968608211056242

Hockham C; Bao L; Tiku A; Badve SV; Bello AK; Jardine MJ; Jha V; Toyama T; Woodward M; Jun M, 2022, 'Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis', Clinical Kidney Journal, vol. 15, pp. 1144 - 1151, http://dx.doi.org/10.1093/ckj/sfac030

Jun M; Scaria A; Andrade J; Badve S; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Ha J; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M, 2022, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, http://dx.doi.org/10.1093/ehjqcco/qcac069

Li C; Yu J; Hockham C; Perkovic V; Neuen BL; Badve SV; Houston L; Lee VYJ; Barraclough JY; Fletcher RA; Mahaffey KW; Heerspink HJL; Cannon CP; Neal B; Arnott C, 2022, 'Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis', Diabetes, Obesity and Metabolism, vol. 24, pp. 1927 - 1938, http://dx.doi.org/10.1111/dom.14772

Lioufas NM; Pascoe EM; Hawley CM; Elder GJ; Badve SV; Block GA; Johnson DW; Toussaint ND, 2022, 'Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD', Journal of the American Society of Nephrology, vol. 33, pp. 59 - 76, http://dx.doi.org/10.1681/ASN.2021040554

Rangan GK; Wong ATY; Munt A; Zhang JQJ; Saravanabavan S; Louw S; Allman-Farinelli M; Badve SV; Boudville N; Chan J; Coolican H; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Gregory AV; Haloob I; Hawley CM; Holt J; Howard K; Howell M; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Pascoe E; Peduto A; Rangan A; Roger SD; Sherfan J; Sud K; Torres VE; Vilayur E; Harris DCH, 2022, 'Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease', NEJM Evidence, vol. 1, http://dx.doi.org/10.1056/evidoa2100021

Badve SV, 2021, 'Editor's note', Internal Medicine Journal, vol. 51, pp. 1368, http://dx.doi.org/10.1111/imj.15462

CHENG L; Badve S; on behalf of the CKD-FIX Study Investigators, L , 2021, 'POS-311 POLYPHARMACY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HIGH PROGRESSION RISK', Kidney International Reports, vol. 6, pp. S134 - S134, http://dx.doi.org/10.1016/j.ekir.2021.03.327

Conley M; Lioufas N; Toussaint ND; Elder GJ; Badve SV; Hawley CM; Pascoe EM; Pedagogos E; Valks A; Campbell KL, 2021, 'Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease', Journal of Renal Nutrition, vol. 31, pp. 155 - 163, http://dx.doi.org/10.1053/j.jrn.2020.02.007

Davies SJ; Zhao J; Morgenstern H; Zee J; Bieber B; Fuller DS; Sloand JA; Vychytil A; Kawanishi H; Johnson DW; Wang AYM; Kanjananbuch T; Boongird S; Moraes TP; Badve SV; Pisoni RL; Perl J, 2021, 'Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS', Kidney International Reports, vol. 6, pp. 313 - 324, http://dx.doi.org/10.1016/j.ekir.2020.11.021

Hultin S; Hood C; Campbell KL; Toussaint ND; Johnson DW; Badve SV, 2021, 'A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes', Kidney International Reports, vol. 6, pp. 695 - 705, http://dx.doi.org/10.1016/j.ekir.2020.12.019

Hultin S; Johnson DW; Badve SV, 2021, 'Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, vol. 30, pp. 467 - 473, http://dx.doi.org/10.1097/MNH.0000000000000728

Jun M; Harris K; Heerspink HJL; Badve SV; Jardine MJ; Harrap S; Hamet P; Marre M; Poulter N; Kotwal S; Gallagher M; Perkovic V; Chalmers J; Woodward M, 2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, vol. 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351

O'Hara DV; Parkhill TR; Badve SV; Jun M; Jardine MJ; Perkovic V, 2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, vol. 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281

Palmer SC; Tendal B; Mustafa RA; Vandvik PO; Li S; Hao Q; Tunnicliffe D; Ruospo M; Natale P; Saglimbene V; Nicolucci A; Johnson DW; Tonelli M; Rossi MC; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque LI; Lloyd A; Ahmad N; Liu Y; Tiv S; Millard T; Gagliardi L; Kolanu N; Barmanray RD; McMorrow R; Raygoza Cortez AK; White H; Chen X; Zhou X; Liu J; Rodríguez AF; González-Colmenero AD; Wang Y; Li L; Sutanto S; Solis RC; Díaz González-Colmenero F; Rodriguez-Gutierrez R; Walsh M; Guyatt G; Strippoli GFM, 2021, 'Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials', The BMJ, vol. 372, http://dx.doi.org/10.1136/bmj.m4573

Tiku A; Johnson DW; Badve SV, 2021, 'Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, vol. 30, pp. 346 - 352, http://dx.doi.org/10.1097/MNH.0000000000000699

Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM, 2020, 'Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants', American Journal of Kidney Diseases, vol. 76, pp. 311 - 320, http://dx.doi.org/10.1053/j.ajkd.2020.02.446

Badve SV; Pascoe EM, 2020, 'Allopurinol and Chronic Kidney Disease. Reply', The New England journal of medicine, vol. 383, pp. 1691 - 1692, http://dx.doi.org/10.1056/NEJMc2026125

Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, vol. 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833

Chen Q; Wang Z; Zhou J; Chen Z; Li Y; Li S; Zhao H; Badve SV; Lv J, 2020, 'Effect of urate-lowering therapy on cardiovascular and kidney outcomes: A systematic review and meta-analysis', Clinical Journal of the American Society of Nephrology, vol. 15, pp. 1576 - 1586, http://dx.doi.org/10.2215/CJN.05190420

Chou A; Long C; Vonthethoff L; Ho SJ; Pettit F; Badve SV, 2020, 'Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery', Canadian Journal of Kidney Health and Disease, vol. 7, http://dx.doi.org/10.1177/2054358120922629

Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; Chen JHC; Sypek M; Johnson DW, 2020, 'Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients', Peritoneal Dialysis International, vol. 40, pp. 47 - 56, http://dx.doi.org/10.1177/0896860819879891

Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND, 2020, 'Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial', American Journal of Nephrology, vol. 51, pp. 201 - 215, http://dx.doi.org/10.1159/000505717

Rangaswamy D; Guddattu V; Webster AC; Borlace M; Boudville N; Clayton P; Badve S; Johnson DW; Sud K, 2020, 'Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry', Peritoneal Dialysis International, vol. 40, pp. 209 - 219, http://dx.doi.org/10.1177/0896860819894058

Toussaint ND; Pedagogos E; Lioufas NM; Elder GJ; Pascoe EM; Badve SV; Valks A; Block GA; Boudville N; Cameron JD; Campbell KL; Chen SSM; Faull RJ; Holt SG; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Hooi LS; Narayan O; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Hawley CM; Wyndham R; Vilayur E; Cooper B; Wong MG; Tan KS; van Eps C; Cho Y; Barbara J; Paizis K; McMahon LP; Nelson C; Gafor AHA; Meng OL; Mushahar L; Maher E, 2020, 'A randomized trial on the effect of phosphate reduction on vascular end points in CKD (improve-CKD)', Journal of the American Society of Nephrology, vol. 31, pp. 2653 - 2666, http://dx.doi.org/10.1681/ASN.2020040411

Walsh M; Merkel PA; Peh C-A; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW, 2020, 'Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis', New England Journal of Medicine, vol. 382, pp. 622 - 631, http://dx.doi.org/10.1056/nejmoa1803537

Wong ATY; Munt A; Allman-Farinelli M; Badve SV; Boudville N; Coolican H; Chandra AN; Coulshed S; Fernando M; Grantham J; Haloob I; Harris DCH; Hawley CM; Holt J; Johnson DW; Kumar K; Lee VW; Lonergan M; Mai J; Rangan A; Roger SD; Saravanabavan S; Sud K; Torres VE; Vilayur E; Zhang JQJ; Rangan GK, 2020, 'Assessment of dietary sodium intake using the scored salt questionnaire in autosomal dominant polycystic kidney disease', Nutrients, vol. 12, pp. 1 - 14, http://dx.doi.org/10.3390/nu12113376

Boudville N; Ullah S; Clayton P; Sud K; Borlace M; Badve SV; Chakera A; Johnson DW, 2019, 'Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies', Nephrology Dialysis Transplantation, vol. 34, pp. 1035 - 1044, http://dx.doi.org/10.1093/ndt/gfy340

Conley M; Toussaint ND; Pedagogos E; Lioufas N; Elder GJ; Badve SV; Hawley CM; Pascoe EM; Valks A; Campbell KL, 2019, 'SAT-224 ESTIMATES OF DIETARY PHOSPHATE CONSUMPTION AND COMMON FOOD SOURCES OF PHOSPHATE IN AUSTRALIANS WITH CHRONIC KIDNEY DISEASE', Kidney International Reports, vol. 4, pp. S100 - S100, http://dx.doi.org/10.1016/j.ekir.2019.05.259

Ha JT; Badve SV; Jun M, 2019, 'Recent evidence for direct oral anticoagulants in chronic kidney disease', Current Opinion in Nephrology and Hypertension, vol. 28, pp. 251 - 261, http://dx.doi.org/10.1097/MNH.0000000000000493

Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, vol. 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087

Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', DIABETES, vol. 68, http://dx.doi.org/10.2337/db19-1216-P

Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, vol. 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5

Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C; Block GA; Boudville NC; Campbell K; Cameron JD; Chen SSM; Faull RJ; Holt SG; Hooi LS; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Morrish A; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM, 2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, vol. 9, pp. e024382, http://dx.doi.org/10.1136/bmjopen-2018-024382

Tennankore K; Zhao J; Karaboyas A; Bieber BA; Robinson BM; Morgenstern H; Jassal SV; Finkelstein FO; Kanjanabuch T; Cheawchanwattana A; Pisoni RL; Sloand JA; Perl J; Johnson D; Sanabria M; Kawanishi H; Kim Y-L; Davies S; Bernardo A; Pisoni R; Robinson B; Shen J; Badve S; Boudville N; Brown F; Chow J; Collins J; Morton R; Wilson S; Vychytil A; Van Biesen W; Figueiredo A; de Moraes T; Brunier G; Jain A; Jassal V; Nessim S; Oliver M; Price V; Quinn R; Szeto CC; Wang A; Fukasawa M; Ito Y; Ryuzaki M; Tomo T; Cueto Manzano A; Marshall M; Ljungman S; Boongird S; Boonyakrai C; Halue G; Sritippayawan S; Tatiyanupanwong S; Tungsanga K; Bowes E; Brown E; Fluck R; Goh BL; Hurst H; Wilkie M; Woodrow G; Bender F; Bernardini J; Chatoth D; Crabtree J; Finkelstein F; Ghaffari A; Mehrotra R; Piraino B; Schreiber M; Teitelbaum I, 2019, 'THE ASSOCIATION OF FUNCTIONAL STATUS WITH MORTALITY AND DIALYSIS MODALITY CHANGE: RESULTS FROM THE PERITONEAL DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (PDOPPS)', PERITONEAL DIALYSIS INTERNATIONAL, vol. 39, pp. 103 - 111, http://dx.doi.org/10.3747/pdi.2018.00094

Viecelli AK; Polkinghorne KR; Pascoe EM; Paul-Brent PA; Hawley CM; Badve SV; Cass A; Hooi LS; Kerr PG; Mori TA; Ong LM; Voss D; Johnson DW; Irish AB, 2019, 'Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial', PLoS ONE, vol. 14, http://dx.doi.org/10.1371/journal.pone.0213274

YEUNG WCG; Talbot B; Shah N; Palmer S; Mangos G; Gallagher M; Toussaint N; Badve S, 2019, 'SUN-292 BENEFITS AND HARMS OF VITAMIN D COMPOUNDS IN ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', Kidney International Reports, vol. 4, pp. S281 - S281, http://dx.doi.org/10.1016/j.ekir.2019.05.797

Yeung WCG; Toussaint ND; Badve SV, 2019, 'Dual inhibition of gastrointestinal phosphate absorption: More questions than answers', Journal of the American Society of Nephrology, vol. 30, pp. 909 - 910, http://dx.doi.org/10.1681/ASN.2019040333

Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2018, 'Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry', American Journal of Kidney Diseases, vol. 71, pp. 814 - 821, http://dx.doi.org/10.1053/j.ajkd.2017.10.017

Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2018, 'Outcomes of acinetobacter peritonitis in peritoneal dialysis patients: A multicenter registry analysis', Peritoneal Dialysis International, vol. 38, pp. 257 - 265, http://dx.doi.org/10.3747/pdi.2017.00199

Htay H; Johnson DW; Wiggins KJ; Badve SV; Craig JC; Strippoli GFM; Cho Y, 2018, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, vol. 2018, http://dx.doi.org/10.1002/14651858.CD007554.pub3

Jegatheesan D; Johnson DW; Cho Y; Pascoe EM; Darssan D; Htay H; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Nadeau-Fredette AC, 2018, 'The relationship between body mass index and organism-specific peritonitis', Peritoneal Dialysis International, vol. 38, pp. 206 - 214, http://dx.doi.org/10.3747/pdi.2017.00188

Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S, 2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, vol. 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2

See E; Johnson D; Hawley C; Pascoe E; Badve S; Boudville N; Clayton P; Sud K; Polkinghorne K; Borlace M; Cho Y, 2018, 'FP468RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', Nephrology Dialysis Transplantation, vol. 33, pp. i194 - i194, http://dx.doi.org/10.1093/ndt/gfy104.fp468

See EJ; Johnson DW; Hawley CM; Pascoe EM; Badve SV; Boudville N; Clayton PA; Sud K; Polkinghorne KR; Borlace M; Cho Y, 2018, 'Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study', American Journal of Kidney Diseases, vol. 72, pp. 188 - 197, http://dx.doi.org/10.1053/j.ajkd.2017.10.019

Tiku A; Badve SV; Johnson DW, 2018, 'Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?', American Journal of Kidney Diseases, vol. 72, pp. 776 - 778, http://dx.doi.org/10.1053/j.ajkd.2018.07.022

Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vliayuri E; Rangan GK, 2018, 'Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)', BMJ Open, vol. 8, http://dx.doi.org/10.1136/bmjopen-2017-018794

Chan S; Cho Y; Koh YH; Boudville NC; Clayton PA; McDonald SP; Pascoe EM; Francis RS; Mudge DW; Borlace M; Badve SV; Sud K; Hawley CM; Johnson DW, 2017, 'Association of socio-economic position with technique failure and mortality in australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, vol. 37, pp. 397 - 406, http://dx.doi.org/10.3747/pdi.2016.00209

Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P, 2017, 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrology, vol. 22, pp. 548 - 554, http://dx.doi.org/10.1111/nep.12815

Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2017, 'Outcomes of corynebacterium peritonitis: A multicenter registry analysis', Peritoneal Dialysis International, vol. 37, pp. 619 - 626, http://dx.doi.org/10.3747/pdi.2017.00028

Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2017, 'Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis', Clinical Journal of the American Society of Nephrology, vol. 12, pp. 1090 - 1099, http://dx.doi.org/10.2215/CJN.12321216

Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR, 2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis a randomized clinical trial', JAMA Internal Medicine, vol. 177, pp. 184 - 193, http://dx.doi.org/10.1001/jamainternmed.2016.8029

Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR, 2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial', Nieren- und Hochdruckkrankheiten, vol. 46, pp. 172 - 173

Lim WH; Badve SV; Wong G, 2017, 'Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - A population cohort study', Oncotarget, vol. 8, pp. 77771 - 77782, http://dx.doi.org/10.18632/oncotarget.20781

Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S, 2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, vol. 2017, http://dx.doi.org/10.1002/14651858.CD009966.pub2

Palmer S; Mavridis D; Nicolucci A; Craig J; Tonelli M; Johnson D; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve S; Cho Y; Nadeau-Fredette A-C; Burke M; Faruque L; Lloyd A; Ahmad N; Tiv S; Liu Y; Wiebe N; Strippoli G, 2017, 'SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', Nephrology Dialysis Transplantation, vol. 32, pp. iii264 - iii265, http://dx.doi.org/10.1093/ndt/gfx149.sp427

Roberts MA; Darssan D; Badve SV; Carroll RP; Fahim MA; Haluska BA; Hawley CM; Isbel NM; Marshall MR; Pascoe EM; Pedagogos E; Pilmore HL; Snelling P; Stanton T; Tan KS; Tonkin AM; Vergara LA; Ierino FL, 2017, 'Carvedilol and cardiac biomarkers in dialysis patients: Secondary analysis of a randomized controlled trial', Kidney and Blood Pressure Research, vol. 42, pp. 1033 - 1044, http://dx.doi.org/10.1159/000485589

See E; Johnson D; Hawley C; Pascoe E; Darssan D; Clayton P; Borlace M; Badve S; Sud K; Boudville N; Cho Y, 2017, 'EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', NEPHROLOGY DIALYSIS TRANSPLANTATION, vol. 32, http://dx.doi.org/10.3747/pdi.2017.00029

See E; Johnson D; Hawley C; Pascoe E; Darssan D; Clayton P; Borlace M; Badve S; Sud K; Boudville N; Cho Y, 2017, 'SP493EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', Nephrology Dialysis Transplantation, vol. 32, pp. iii294 - iii294, http://dx.doi.org/10.1093/ndt/gfx151.sp493

Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi LS; Ong LM; Irish AB, 2017, 'Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, vol. 22, pp. 823 - 824, http://dx.doi.org/10.1111/nep.12823

Wong G; Au E; Badve SV; Lim WH, 2017, 'Breast Cancer and Transplantation', American Journal of Transplantation, vol. 17, pp. 2243 - 2253, http://dx.doi.org/10.1111/ajt.14368

Yeung WC; Badve SV; Pascoe E; Hawley CM; Clayton PA; McDonald SP; Lim WH; Wong G; Chadban SJ; Campbell SB; Johnson DW, 2017, 'TEMPORAL TRENDS IN CLINICAL OUTCOMES OF KIDNEY TRANSPLANTATION FROM 1996 TO 2013 IN AUSTRALIA AND NEW ZEALAND', NEPHROLOGY, vol. 22, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408833200309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; Liu X; McTaggart S; Morrish AT; Playford G; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2017, 'Representativeness of honeypot trial participants to Australasian PD patients', Peritoneal Dialysis International, vol. 37, pp. 516 - 522, http://dx.doi.org/10.3747/pdi.2016.00065

Badve SV; Palmer SC; Hawley CM; Pascoe EM; Strippoli GFM; Johnson DW, 2016, 'Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials', Nephrology Dialysis Transplantation, vol. 31, pp. 1425 - 1436, http://dx.doi.org/10.1093/ndt/gfv269

Badve SV; Palmer SC; Strippoli GFM; Roberts MA; Teixeira-Pinto A; Boudville N; Cass A; Hawley CM; Hiremath SS; Pascoe EM; Perkovic V; Whalley GA; Craig JC; Johnson DW, 2016, 'The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, vol. 68, pp. 554 - 563, http://dx.doi.org/10.1053/j.ajkd.2016.03.418

Badve SV; Pascoe EM; Burke M; Clayton PA; Campbell SB; Hawley CM; Lim WH; McDonald SP; Wong G; Johnson DW, 2016, 'Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients', Clinical Journal of the American Society of Nephrology, vol. 11, pp. 1845 - 1855, http://dx.doi.org/10.2215/CJN.00190116

Lan PG; Clayton PA; Johnson DW; McDonald SP; Borlace M; Badve SV; Sud K; Boudville N, 2016, 'Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure', Peritoneal Dialysis International, vol. 36, pp. 623 - 630, http://dx.doi.org/10.3747/pdi.2015.00218

Nadeau-Fredette AC; Johnson DW; Hawley CM; Pascoe EM; Cho Y; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP, 2016, 'Center-specific factors associated with peritonitis risk—a multi-center registry analysis', Peritoneal Dialysis International, vol. 36, pp. 509 - 518, http://dx.doi.org/10.3747/pdi.2015.00146

Palmer SC; Mavridis D; Nicolucci A; Johnson DW; Tonelli M; Craig JC; Maggo J; Gray V; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque L; Lloyd A; Ahmad N; Liu Y; Tiv S; Wiebe N; Strippoli GFM, 2016, 'Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis', JAMA - Journal of the American Medical Association, vol. 316, pp. 313 - 324, http://dx.doi.org/10.1001/jama.2016.9400

Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Isbel NM; Krum H; Pascoe EM; Perkovic V; Scaria A; Tonkin AM; Vergara LA; Hawley CM; Levin A; Hare D; Martin A; Wheeler DC; Fulcher G; Brown H; Colquhoun D; Korczyk D; Mather A; Wong A; Bisscheroux P; Gillies A; Garvey L; Tan KS; Lennan E; Pitkin M; Ahearn K; Carroll RP; Scott E; Cooper B; Pearse J; Snelling P; Burman J; Hand S; Pedagogos E; Karschimkus C; Pilmore A; Walker R; Ellis G; Marshall MR; Paul C; Johnson D; Helyar J; Morrish A; Paul-Brent PA; Reidlinger D; Zhang L, 2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, vol. 67, pp. 902 - 911, http://dx.doi.org/10.1053/j.ajkd.2015.10.029

Sukkar L; Hong D; Wong MG; Badve SV; Perkovic V; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, vol. 31, pp. i413 - i413, http://dx.doi.org/10.1093/ndt/gfw187.27

Sukkar L; Hong D; Wong MG; Badve SV; Rogers K; Perkovic V; Walsh M; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ (Online), vol. 355, http://dx.doi.org/10.1136/bmj.i5599

Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi SL; Ong ML; Irish AB, 2016, 'Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, vol. 21, pp. 217 - 228, http://dx.doi.org/10.1111/nep.12573

Young V; Balaam S; Orazio L; Bates A; Badve SV; Johnson DW; Campbell KL, 2016, 'Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis', Journal of Renal Care, vol. 42, pp. 123 - 131, http://dx.doi.org/10.1111/jorc.12156

Zhang L; Coombes J; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, vol. 21, pp. 14 - 23, http://dx.doi.org/10.1179/1351000215Y.0000000022

Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW, 2016, 'Long-term outcomes of end-stage kidney disease for patients with lupus nephritis', Kidney International, vol. 89, pp. 1337 - 1345, http://dx.doi.org/10.1016/j.kint.2016.02.014

Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW, 2016, 'Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study', Nephrology, vol. 21, pp. 387 - 396, http://dx.doi.org/10.1111/nep.12629

Azzam O; Sud K; Clayton P; Johnson D; Badve S; Borlace M; Mcdonald S; Boudville N, 2015, 'DISPARITIES IN SURVIVAL OF DIALYSIS PATIENTS IN AUSTRALIA BASED UPON ETHNICITY AND COUNTRY OF BIRTH', NEPHROLOGY, vol. 20, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Burke M; Clayton P; Campbell SB; Hawley CM; Lim WH; Mcdonald SP; Pascoe E; Wong G; Johnson DW, 2015, 'MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AND CLINICAL OUTCOMES IN ADULT KIDNEY TRANSPLANT RECIPIENTS', NEPHROLOGY, vol. 20, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Palmer SC; Johnson DW; Strippoli GFM, 2015, 'A nephrology guide to reading and using systematic reviews of randomized trials', Nephrology Dialysis Transplantation, vol. 30, pp. 878 - 884, http://dx.doi.org/10.1093/ndt/gfu222

Badve SV; Zhang L; Coombes JS; Pascoe EM; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R, 2015, 'Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: A secondary analysis of the HERO trial', Canadian Journal of Kidney Health and Disease, vol. 2, http://dx.doi.org/10.1186/s40697-015-0066-5

Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; D'Almeida E; Fassett R; Kirkpatrick C; Phoon R; Tonkin A; Forbes A; Levin A; Wheeler DC; Jardine M; Burman J; Hand S; Garvey L; Suranyi M; Gilbert M; Endre Z; McNamara K; Snelling P; Mahadevan K; Pollock A; Leary D; Ratanjee S; Kirby J; Juneja R; Hill K; Cook N; Bisscheroux P; McMahon L; Kent A; Raspudic M; Steinwandel U; Dogra S; Pellicano S; Paul-Brent PA, 2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, vol. 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020

Lo C; Toyama T; Hirakawa Y; Jun M; Cass A; Hawley C; Pilmore H; Badve S; Perkovic V; Zoungas S, 2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, vol. 2015, http://dx.doi.org/10.1002/14651858.CD011798

Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW, 2015, 'End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy-Outcomes in 66 consecutive ANZDATA registry cases', American Journal of Nephrology, vol. 42, pp. 177 - 184, http://dx.doi.org/10.1159/000440815

Nadeau-Fredette AC; Badve SV; Johnson DW, 2015, 'Daily home hemodialysis: Balancing cardiovascular benefits with infectious harms', American Journal of Kidney Diseases, vol. 65, pp. 6 - 8, http://dx.doi.org/10.1053/j.ajkd.2014.08.012

Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Hawley CM; Isbel NM; Krum H; Pascoe EM; Tonkin AM; Vergara LA; Perkovic V, 2015, 'The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study', Nephrology, vol. 20, pp. 140 - 147, http://dx.doi.org/10.1111/nep.12362

Stevenson S; Tang W; Cho Y; Mudge DW; Hawley CM; Badve SV; Johnson DW, 2015, 'The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, vol. 35, pp. 222 - 228, http://dx.doi.org/10.3747/pdi.2013.00156

Tang W; Grace B; McDonald SP; Hawley CM; Badve SV; Boudville NC; Brown FG; Clayton PA; Johnson DW, 2015, 'Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, vol. 35, pp. 450 - 459, http://dx.doi.org/10.3747/pdi.2013.00004

Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB, 2015, 'The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: The updated final trial protocol and rationale of post-initiation trial modifications', BMC Nephrology, vol. 16, http://dx.doi.org/10.1186/s12882-015-0089-2

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; De Zoysa J; Isbel NM; McTaggart S; Morrish AT; Geoffrey Playford E; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2015, 'The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: A sub-study of the Honeypot trial', Peritoneal Dialysis International, vol. 35, pp. 712 - 721, http://dx.doi.org/10.3747/pdi.2014.00206

Badve SV; Johnson DW, 2014, 'Chronic kidney disease: haemodialysis catheter care in practice.', Nature reviews. Nephrology, vol. 10, pp. 131 - 133, http://dx.doi.org/10.1038/nrneph.2014.3

Badve SV; Paul SK; Klein K; Clayton PA; Hawley CM; Brown FG; Boudville N; Polkinghorne KR; McDonald SP; Johnson DW, 2014, 'The association between body mass index and mortality in incident dialysis patients', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0114897

Badve SV; Roberts MA; Palmer SC; Hiremath SS; Hawley CM; Perkovic V; Whalley GA; Strippoli GFM; Johnson DW, 2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, vol. 19, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bose B; Badve SV; Hiremath SS; Boudville N; Brown FG; Cass A; De Zoysa JR; Fassett RG; Faull R; Harris DC; Hawley CM; Kanellis J; Palmer SC; Perkovic V; Pascoe EM; Rangan GK; Walker RJ; Walters G; Johnson DW, 2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, vol. 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Clayton P; Johnson DW, 2014, 'Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis', Nephrology Dialysis Transplantation, vol. 29, pp. 1940 - 1947, http://dx.doi.org/10.1093/ndt/gfu050

Cho Y; Johnson DW; Craig JC; Strippoli GFM; Badve SV; Wiggins KJ, 2014, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, vol. 2014, http://dx.doi.org/10.1002/14651858.CD007554.pub2

Cho Y; Johnson DW; Craig JC; Strippoli GFM; Badve SV; Wiggins KJ, 2014, 'Biocompatible dialysis fluids for peritoneal dialysis.', The Cochrane database of systematic reviews, vol. 3

Johnson DW; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM, 2014, 'Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial', The Lancet Infectious Diseases, vol. 14, pp. 23 - 30, http://dx.doi.org/10.1016/S1473-3099(13)70258-5

Johnson DW; Pascoe E; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Scaria A; Walker R; Vergara LA; Hawley CM, 2014, 'A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL', NEPHROLOGY, vol. 19, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lan PG; Johnson DW; McDonald SP; Boudville N; Borlace M; Badve SV; Sud K; Clayton PA, 2014, 'The association between peritoneal dialysis modality and peritonitis', Clinical Journal of the American Society of Nephrology, vol. 9, pp. 1091 - 1097, http://dx.doi.org/10.2215/CJN.09730913

Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW, 2014, 'End-stage kidney disease due to alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases', Nephrology Dialysis Transplantation, vol. 29, pp. 2277 - 2286, http://dx.doi.org/10.1093/ndt/gfu254

Morrish AT; Hawley CM; Johnson DW; Badve SV; Perkovic V; Reidlinger DM; Cass A, 2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, vol. 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391

Tang W; Cho Y; Hawley CM; Badve SV; Johnson DW, 2014, 'The role of monitoring Gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, vol. 34, pp. 219 - 226, http://dx.doi.org/10.3747/pdi.2012.00318

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; De Zoysa J; Isbel NM; Mctaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2014, 'MICROBIOLOGICAL RESULTS OF THE HONEYPOT STUDY - SECONDARY ANALYSIS OF A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS', NEPHROLOGY, vol. 19, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhang L; Pascoe EM; Badve SV; Cass A; Clarke P; Coombes JS; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, vol. 19, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Beller EM; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, vol. 2013, http://dx.doi.org/10.1002/14651858.CD006861.pub3

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Bannister KM; Clayton PA; Johnson DW, 2013, 'Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes', Clinical Journal of the American Society of Nephrology, vol. 8, pp. 1556 - 1563, http://dx.doi.org/10.2215/CJN.12361212

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton P; Johnson DW, 2013, 'Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study', Peritoneal Dialysis International, vol. 33, pp. 75 - 85, http://dx.doi.org/10.3747/pdi.2011.00317

Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GFK; Wiggins KJ, 2013, 'Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, vol. 28, pp. 1899 - 1907, http://dx.doi.org/10.1093/ndt/gft050

Cho Y; Johnson DW; Badve SV; Craig JC; Strippoli GFM; Wiggins KJ, 2013, 'The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients', Kidney International, vol. 84, pp. 969 - 979, http://dx.doi.org/10.1038/ki.2013.190

Johnson D; Badve S; Pascoe E; Beller E; Cass A; Clark C; De Zoysa J; Mctaggart S; Isbel N; Morrish A, 2013, 'A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS - HONEYPOT STUDY', NEPHROLOGY, vol. 18, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Krishnasamy R; Badve SV; Hawley CM; McDonald SP; Boudville N; Brown FG; Polkinghorne KR; Bannister KM; Wiggins KJ; Clayton P; Johnson DW, 2013, 'Daily variation in death in patients treated by long-term dialysis: Comparison of in-center hemodialysis to peritoneal and home hemodialysis', American Journal of Kidney Diseases, vol. 61, pp. 96 - 103, http://dx.doi.org/10.1053/j.ajkd.2012.07.008

Pascoe EM; Lo S; Scaria A; Badve SV; Beller EM; Cass A; Hawley CM; Johnson DW, 2013, 'The honeypot randomized controlled trial statistical analysis plan', Peritoneal Dialysis International, vol. 33, pp. 426 - 435, http://dx.doi.org/10.3747/pdi.2012.00310

Tang W; Bose B; Mcdonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW, 2013, 'The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand', Clinical Journal of the American Society of Nephrology, vol. 8, pp. 773 - 780, http://dx.doi.org/10.2215/CJN.08770812

Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; De Zoysa JR; Johnson DW, 2013, 'End-stage renal failure due to amyloidosis: Outcomes in 490 ANZDATA registry cases', Nephrology Dialysis Transplantation, vol. 28, pp. 455 - 461, http://dx.doi.org/10.1093/ndt/gfs492

Tang W; Mcdonald SP; Hawley CM; Badve SV; Boudville NC; Brown FG; Clayton PA; Campbell SB; De Zoysa JR; Johnson DW, 2013, 'Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease', Kidney International, vol. 83, pp. 503 - 510, http://dx.doi.org/10.1038/ki.2012.375

Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville NC; Wiggins KJ; Bannister KM; Johnson DW, 2012, 'Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function', Nephrology Dialysis Transplantation, vol. 27, pp. 381 - 387, http://dx.doi.org/10.1093/ndt/gfr274

Bose B; Mallett A; Badve SV; Johnson DW; Hawley C; Mudge D; Van Eps C; Campbell S; Isbel N, 2012, 'TWO CASES OF ATYPICAL HAEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB', NEPHROLOGY, vol. 17, pp. 91 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Boudville N; Kemp A; Clayton P; Lim W; Badve SV; Hawley CM; McDonald SP; Wiggins KJ; Bannister KM; Brown FG; John DW, 2012, 'Recent peritonitis associates with mortality among patients treated with peritoneal dialysis', Journal of the American Society of Nephrology, vol. 23, pp. 1398 - 1405, http://dx.doi.org/10.1681/ASN.2011121135

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton PA; Johnson DW, 2012, 'Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study.', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 27, pp. 2028 - 2036, http://dx.doi.org/10.1093/ndt/gfr582

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; M NB; Wiggins KJ; Bannister KM; Clayton P; Johnson DW, 2012, 'The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: A multi-centre registry study', BMC Nephrology, vol. 13, http://dx.doi.org/10.1186/1471-2369-13-41

Cho Y; Badve SV; Hawley CM; Wiggins K; Johnson DW, 2012, 'Biocompatible peritoneal dialysis fluids: Clinical outcomes', International Journal of Nephrology, vol. 2012, http://dx.doi.org/10.1155/2012/812609

Johnson DW; Clayton P; Cho Y; Badve SV; Hawley CM; McDonald S; Boudville N; Wiggins KJ; Bannister K; Brown F, 2012, 'Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, vol. 32, pp. 516 - 524, http://dx.doi.org/10.3747/pdi.2011.00169

Jun M; Badve SV; Hawley CM; Pilmore H; White S; Cass A; Perkovic V; Zoungas S, 2012, 'Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD009966

Lee A; Killen J-P; Hawley C; Jeffries J; Equinox K; Johnson D; Campbell S; Isbel N; Mudge D; Badve S; Van Eps C, 2012, 'NXSTAGE QUEENSLAND HEALTH PILOT PROGRAM THE EARLY AUSTRALIAN NXSTAGE EXPERIENCE: IS NXSTAGE REALLY THE NEXT STAGE IN HOME HAEMODIALYSIS?', NEPHROLOGY, vol. 17, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mudge DW; Tan KS; Miles R; Johnson DW; Badve SV; Campbell SB; Isbel NM; Van Eps CL; Hawley CM, 2012, 'A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation', Transplantation, vol. 93, pp. 822 - 826, http://dx.doi.org/10.1097/TP.0b013e318248375a

Roberts MA; Pilmore HL; Tonkin AM; Garg AX; Pascoe EM; Badve SV; Cass A; Ierino FL; Hawley CM, 2012, 'Challenges in blood pressure measurement in patients treated with maintenance hemodialysis', American Journal of Kidney Diseases, vol. 60, pp. 463 - 472, http://dx.doi.org/10.1053/j.ajkd.2012.04.026

Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW, 2012, 'End-stage kidney disease due to haemolytic uraemic syndrome - Outcomes in 241 consecutive ANZDATA registry cases', BMC Nephrology, vol. 13, http://dx.doi.org/10.1186/1471-2369-13-164

Thirugnanasambathan T; Hawley CM; Badve SV; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton P; Johnson DW, 2012, 'Repeated peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, vol. 59, pp. 84 - 91, http://dx.doi.org/10.1053/j.ajkd.2011.06.018

Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ, 2012, 'Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk', Nephrology, vol. 17, pp. 433 - 444, http://dx.doi.org/10.1111/j.1440-1797.2012.01618.x

Woditschka S; Palmieri D; Duchnowska R; Jassem J; Badve S; Sledge GW; Steeg PS, 2012, 'Overexpression of RAD51 promotes brain metastases from breast cancer', CANCER RESEARCH, vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-5306

Young V; Orazio L; Badve SV; Bates A; Johnson DW; Campbell KL, 2012, 'IMPACTS ON PROTEIN INTAKE IN PERITONEAL DIALYSIS PATIENTS', Kidney Research and Clinical Practice, vol. 31, pp. A87 - A87, http://dx.doi.org/10.1016/j.krcp.2012.04.606

Agarwal R, 2011, 'Frequent versus Standard Hemodialysis', NEW ENGLAND JOURNAL OF MEDICINE, vol. 364, pp. 975 - 976, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288170300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Brown F; Hawley CM; Johnson DW; Kanellis J; Rangan GK; Perkovic V, 2011, 'Challenges of conducting a trial of uric-acid-lowering therapy in CKD', Nature Reviews Nephrology, vol. 7, pp. 295 - 300, http://dx.doi.org/10.1038/nrneph.2010.186

Badve SV; Hawley CM; Johnson DW, 2011, 'Frequent versus standard hemodialysis.', N Engl J Med, vol. 364, pp. 975, http://dx.doi.org/10.1056/NEJMc1100105

Badve SV; Hawley CM; Johnson DW, 2011, 'Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?', Nephrology, vol. 16, pp. 144 - 153, http://dx.doi.org/10.1111/j.1440-1797.2010.01407.x

Badve SV; Roberts MA; Hawley CM; Cass A; Garg AX; Krum H; Tonkin A; Perkovic V, 2011, 'Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, vol. 58, pp. 1152 - 1161, http://dx.doi.org/10.1016/j.jacc.2011.04.041

Bose B; McDonald SP; Hawley CM; Brown FG; Badve SV; Wiggins KJ; Bannister KM; Boudville N; Clayton P; Johnson DW, 2011, 'Effect of dialysis modality on survival of hepatitis C-infected ESRF patients', Clinical Journal of the American Society of Nephrology, vol. 6, pp. 2657 - 2661, http://dx.doi.org/10.2215/CJN.02200311

Burke M; Hawley CM; Badve SV; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Johnson DW, 2011, 'Relapsing and recurrent peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, vol. 58, pp. 429 - 436, http://dx.doi.org/10.1053/j.ajkd.2011.03.022

Badve S; Beller E; Cass A; Francis D; Hawley C; Macdougall I; Perkovic V; Johnson D, 2010, 'INTERVENTIONS FOR ERYTHROPOIETIN-RESISTANT ANAEMIA IN DIALYSIS PATIENTS: A SYSTEMATIC REVIEW', NEPHROLOGY, vol. 15, pp. 80 - 80, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve S; Hawley C; Perkovic V; Cass A; Roberts M, 2010, 'beta-RECEPTOR ANTAGONISTS IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS', NEPHROLOGY, vol. 15, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Burke M; Hawley C; Badve S; McDonald S; Brown F; Rosman J; Wiggins K; Bannister K; Johnson D, 2010, 'RELAPSING AND RECURRENT PERITONEAL DIALYSIS - ASSOCIATED PERITONITIS: INCIDENCE, CAUSES, PREDICTORS AND OUTCOMES', NEPHROLOGY, vol. 15, pp. 57 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV, 2010, 'Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis', Nephrology Dialysis Transplantation, vol. 25, pp. 1973 - 1979, http://dx.doi.org/10.1093/ndt/gfp780

Thirugnanasambanthan T; Hawley C; Badve S; McDonald S; Brown F; Rosman J; Wiggins K; Bannister K; Johnson D, 2010, 'REPEAT PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS: INCIDENCE, CAUSES, PREDICTORS AND OUTCOMES', NEPHROLOGY, vol. 15, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Smith A; Hawley CM; Johnson DW, 2009, 'Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients', NDT Plus, vol. 2, pp. 508, http://dx.doi.org/10.1093/ndtplus/sfp095

Cho Y; Johnson DW; Craig JC; Strippoli GFM; Badve SV; Wiggins KJ, 2009, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD007554

Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW, 2008, 'Automated and continuous ambulatory peritoneal dialysis have similar outcomes', Kidney International, vol. 73, pp. 480 - 488, http://dx.doi.org/10.1038/sj.ki.5002705

Badve SV; McCormick BB, 2008, 'Phosphate balance on peritoneal dialysis', PERITONEAL DIALYSIS INTERNATIONAL, vol. 28, pp. S26 - S32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257889700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB, 2008, 'Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics', Clinical Journal of the American Society of Nephrology, vol. 3, pp. 1711 - 1717, http://dx.doi.org/10.2215/CJN.00190108

Wiggins KJ; Craig JC; Johnson DW; Strippoli GF, 2008, 'Treatment for peritoneal dialysis-associated peritonitis', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.CD005284.pub2

Badve SV; Magner PO, 2007, 'Does Sevelamer reduce mortality by slowing of progression of coronary calcification? [9]', Kidney International, vol. 71, pp. 1328 - 1329, http://dx.doi.org/10.1038/sj.ki.5002316

Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW, 2006, 'Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations', Nephrology Dialysis Transplantation, vol. 21, pp. 776 - 783, http://dx.doi.org/10.1093/ndt/gfi248

Tapiawala S; Vora H; Patel Z; Badve S; Shah B, 2006, 'Subjective global assessment of nutritional status of patients with chronic renal insufficiency and end stage renal disease on dialysis', Journal of Association of Physicians of India, vol. 54, pp. 923 - 926

Badve S, 2005, 'Food for thought.', Annals of internal medicine, vol. 143, pp. 149, http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00017

Shroff GR; Badve SV; Joshi AG; Desai DC; Abraham P; Sirsat RA, 2004, 'Acute renal tubular injury with acute hepatitis a infection: Is it just a coincidence?', Nephrology, vol. 9, pp. 44 - 46, http://dx.doi.org/10.1111/j.1440-1797.2003.00224.x

Tapiawala S; Badve SV; More N; Shah BV, 2004, 'Severe muscle weakness due to hyperkalemia', Journal of Association of Physicians of India, vol. 52, pp. 505 - 506

Kulkarni AA; Badve SV; Tapiawala SN; Deshpande RB; Shah BV, 2003, 'Cytomegalovirus nasal polyp after renal transplant', Journal of Association of Physicians of India, vol. 51, pp. 614 - 615

Conley M; Campbell KL; Hawley CM; Lioufas NM; Elder GJ; Badve SV; Pedagogos E; Milanzi E; Pascoe EM; Valks A; Toussaint ND, 2022, 'Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease', in Journal of Renal Nutrition, WILEY, Vol. 32, pp. 58 - 67, http://dx.doi.org/10.1053/j.jrn.2021.07.004

Hudson R; Pascoe EM; See YP; Cho Y; Polkinghorne KR; Paul-Brent PA; Hooi LS; Ong LM; Mori TA; Badve SV; Cass A; Kerr PG; Voss D; Hawley CM; Johnson DW; Irish AB; Viecelli AK, 2022, 'A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial', in Journal of Vascular Access, WILEY-BLACKWELL, Vol. 21, pp. 115 - 116, http://dx.doi.org/10.1177/11297298221099134

Lioufas N; Pascoe E; Hawley C; Elder G; Badve S; Block G; Johnson D; Toussaint N, 2021, 'EFFECTS OF PHOSPHATE-LOWERING THERAPY IN NON-DIALYSIS CHRONIC KIDNEY DISEASE - A SYSTEMATIC REVIEW AND META-ANALYSES', in NEPHROLOGY, WILEY, Vol. 26, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000689277100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Boudville N; Brown F; Cass A; Clarke P; Day R; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Pascoe E; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S; Dalbeth N, 2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jun M; Jardine M; Heerspink HL; Perkovic V; Badve S; Kotwal S; Gallagher M; Harris K; Chalmers J; Woodward M, 2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, Vol. 25, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kotwal S; Mehta Y; Lee V; Mallawarchchi A; Ritchie A; Wong M; Makris A; Badve S; Yong K; Jardine M; Perkovic V; Bose B, 2020, 'GLOMERULAR DISEASE REGISTRY AND BIOBANK (GRIT)', in NEPHROLOGY, WILEY, Vol. 25, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mahaffey KW; Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; de Zeeuw D; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S340 - S341, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303803039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lioufas N; Toussaint N; Pedagogos E; Elder G; Badve S; Pascoe E; Valks A; Hawley C, 2018, 'IMPROVING CARDIOVASCULAR OUTCOMES THROUGH PHOSPHATE LOWERING IN CKD? BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE 'IMPACT OF PHOSPHATE REDUCTION ON VASCULAR END-POINTS IN CHRONIC KIDNEY DISEASE' (IMPROVE-CKD) STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

See E; Johnson D; Hawley C; Pascoe E; Badve S; Boudville N; Clayton P; Sud K; Polkinghorne K; Borlace M; Cho Y, 2018, 'RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, DENMARK, Copenhagen, Vol. 33, presented at 55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), DENMARK, Copenhagen, 24 May 2018 - 27 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433059800530&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lim W; Yeung W-C; Campbell S; Chadban S; Clayton P; Hawley C; Johnson D; McDonald S; Pascoe E; Wong G; Badve S, 2017, 'Trends in Long-Term Outcomes of Kidney Transplantation in Australia and New Zealand', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY, IL, Chicago, Vol. 17, pp. 795 - 796, presented at American Transplant Congress, IL, Chicago, 29 April 2017 - 03 May 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404515704556&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Palmer S; Mavridis D; Nicolucci A; Craig J; Tonelli M; Johnson D; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve S; Cho Y; Nadeau-Fredette A-C; Burke M; Faruque L; Lloyd A; Ahmad N; Tiv S; Liu Y; Wiebe N; Strippoli G, 2017, 'GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469797101164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Irish A; Viecelli A; Hawley C; Hooi L; Pascoe E; Paul-Brent P; Badve S; Mori T; Cass A; Kerr P; Voss D; Ong L; Polkinghorne K, 2016, 'EFFECT OF FISH OIL AND ASPIRIN ON ARTERIOVENOUS FISTULA FAILURE IN HAEMODIALYSIS - A RANDOMIZED CONTROLLED TRIAL', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 47 - 47, http://dx.doi.org/10.1111/nep.12884

Roberts M; Badve S; Carroll R; Darssan D; Fahim M; Hawley C; Isbel N; Marshall M; Pascoe E; Pedagogos E; Pilmore H; Snelling P; Tan K; Tonkin A; Vergara L; Ierino F, 2016, 'CARDIOVASCULAR BIOMARKERS, GLOBAL LEFT VENTRICULAR STRAIN, AND TOLERABILITY OF THE BETA-BLOCKER CARVEDILOL IN PATIENTS RECEIVING DIALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 95 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Roberts M; Badve S; Carroll R; Darssan D; Fahim M; Hawley C; Isbel N; Marshall M; Pascoe E; Pedagogos E; Pilmore H; Snelling P; Tan K; Tonkin A; Vergara L; Ierino F, 2016, 'EFFECT OF THE BETA-BLOCKER CARVEDILOL ON BIOMARKERS OF CARDIOVASCULAR DISEASE IN PATIENTS RECEIVING DIALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 94 - 94, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sukkar L; Hong D; Wong M; Badve S; Rogers K; Perkovic V; Walsh M; Yu X; Hillis G; Gallagher M; Jardine M, 2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 21, pp. 108 - 108, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sukkar L; Hong D; Wong MG; Badve SV; Perkovic V; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, AUSTRIA, Vienna, pp. 413 - 413, presented at 53rd ERA-EDTA Congress, AUSTRIA, Vienna, 21 May 2016 - 24 May 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376653801474&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chen Q; Wang Z; Zhou J; Chen Z; Li Y; Li S; Zhao H; Badve SV; Lv J, Effect of Urate-Lowering Therapy on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis, http://dx.doi.org/10.2139/ssrn.3506167